Abiomed (FRA:AIO) Short-Term Capital Lease Obligation : €0 Mil (As of Sep. 2022)

View and export this data going back to 1987. Start your Free Trial

What is Abiomed Short-Term Capital Lease Obligation?

Abiomed's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2022 was €0 Mil.

Abiomed Short-Term Capital Lease Obligation Historical Data

The historical data trend for Abiomed's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abiomed Short-Term Capital Lease Obligation Chart

Abiomed Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

Abiomed Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	-	-	-	-

Abiomed Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Abiomed Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Abiomed's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Abiomed (FRA:AIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abiomed Inc (FRA:AIO) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

22 Cherry Hill Drive, Danvers, MA, USA, 01923

Website

https://www.abiomed.com

Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.